NexgenRx Inc.
NXG.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 4,242.44% | 1,124.09% | 285.90% | 182.73% | 90.51% |
| Total Depreciation and Amortization | 15.21% | 7.61% | 12.09% | -82.53% | -81.39% |
| Total Amortization of Deferred Charges | -9.14% | -9.14% | -9.14% | -- | -- |
| Total Other Non-Cash Items | 276.71% | 512.70% | 493.23% | -54.01% | -56.77% |
| Change in Net Operating Assets | -475.71% | -479.40% | -720.97% | 25.79% | 175.28% |
| Cash from Operations | 7.81% | 41.61% | -34.40% | 146.36% | 54.17% |
| Capital Expenditure | -179.67% | -9.20% | -8.90% | -125.88% | 64.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -183.17% | -126.59% | -172.86% | -22.19% | 20.66% |
| Cash from Investing | -181.71% | -92.00% | -122.02% | -482.20% | 46.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -40.38% | -39.95% | -29.17% | -25.13% | 2.51% |
| Issuance of Common Stock | -66.67% | -66.67% | 200.00% | 200.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 37.37% | 39.60% | 39.36% | -66.50% | 5.83% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 21.39% | 25.20% | 49.77% | -50.96% | 24.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.98% | 418.23% | -250.06% | -97.58% | 204.79% |